Pharmaceutical Drugs And Biologics Market Global Report 2017
出 版 商：TBRC
出版日期：2017/07/17
頁 數：350頁
文件格式：PDF
價 格：
USD 8,000 (Single-User License)
USD 12,000 (Multi-User License)
USD 16,000 (Global-User License)
USD 8,000 (Hard copy)
USD 12,000 (Multi-User License)
USD 16,000 (Global-User License)
USD 8,000 (Hard copy)
The pharmaceutical industry is moving away from animal testing towards cheaper and more efficient technologies. For example, LiverChip technology created an alternative model of testing which uses a 3D cell culture platform that mimics the architecture and physiology of a human being, which was significantly less expensive and more efficient than animal testing.
The Pharmaceutical Drugs And Biologics Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical drugs and biologics sector.
Reasons to Purchase
‧ Outperform competitors using accurate up to date demand-side dynamics information.
‧ Identify growth segments for investment.
‧ Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Stay abreast of the latest customer and market research findings
‧ Benchmark performance against key competitors.
‧ Develop strategies based on likely future developments.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Gain a global perspective on the development of the market.
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the pharmaceutical drugs and biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs and biologics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider healthcare market, and compares it with other markets.
‧ The market characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
‧ The pharmaceutical drugs and biologics market section of the report gives context. It compares the pharmaceutical drugs and biologics market with other segments of the healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Pharmaceutical Drugs And Biologics Indicators Comparison.
‧ The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Pharmaceuticals, Biologics, Pharmaceutical Drugs
Companies Mentioned: Pfizer, Roche, Glaxosmithkline, Merck & Co., and Sanofi
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Pharmaceutical Drugs And Biologics Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
The Pharmaceutical Drugs And Biologics Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical drugs and biologics sector.
Reasons to Purchase
‧ Outperform competitors using accurate up to date demand-side dynamics information.
‧ Identify growth segments for investment.
‧ Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Stay abreast of the latest customer and market research findings
‧ Benchmark performance against key competitors.
‧ Develop strategies based on likely future developments.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Gain a global perspective on the development of the market.
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the pharmaceutical drugs and biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs and biologics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider healthcare market, and compares it with other markets.
‧ The market characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
‧ The pharmaceutical drugs and biologics market section of the report gives context. It compares the pharmaceutical drugs and biologics market with other segments of the healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Pharmaceutical Drugs And Biologics Indicators Comparison.
‧ The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Pharmaceuticals, Biologics, Pharmaceutical Drugs
Companies Mentioned: Pfizer, Roche, Glaxosmithkline, Merck & Co., and Sanofi
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Pharmaceutical Drugs And Biologics Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
1. Pharmaceutical Drugs And Biologics Market Characteristics;
2. Pharmaceutical Drugs And Biologics Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; Aging Populations; Emerging Markets Growth; Health Insurance Reforms; 2.1.2. Restraints On The Market; Patent Expiration Of Drugs; Pricing Pressures From Regulators; High Costs Of Drug Approval; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; Economic Growth; Technology; Changes In Lifestyles; New Methods For Drug Discovery; 2.2.2. Restraints On The Market; Cost; Interest Rate Increases; Reduction In Free Trade;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Pharmaceutical Drugs And Biologics Market Customer Information;
5. Pharmaceutical Drugs And Biologics Market Segmentation;
5.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 5.2. Global Pharmaceutical Drugs And Biologics Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Pharmaceutical Drugs And Biologics Market Trends And Strategies; Turning Away From Animal Testing; Increase In Personalized Medicine; Collaboration Driving Innovation; Increase In Mergers And Acquisitions; Rise Of Biologics/Gene Therapy; Aggressive Pricing Changes In Some Drugs; 5.4 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016; 5.5 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2012 – 2020, Historic and Forecast; 5.6 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Region; 5.7 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Country; 5.8 Pharmaceutical Drugs; 5.8.1. Market Characteristics; 5.8.2. Global Pharmaceutical Drugs Market, 2016, By Segment; 5.8.3. Global Pharmaceutical Drugs Market, 2012 – 2020, Historic and Forecast, By Segment; 5.8.4. Market Trends And Strategies; 5.9 Biologics; 5.9.1. Market Characteristics; 5.9.2. Global Biologics Market, 2016, By Segment; 5.9.3. Global Biologics Market, 2012 – 2020, Historic and Forecast, By Segment; 5.9.4. Market Trends And Strategies;
6. Pharmaceutical Drugs And Biologics Market Regional And Country Analysis;
6.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Region; 6.2. Global Pharmaceutical Drugs And Biologics Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Pharmaceutical Drugs And Biologics Market, 2016, By Country; 6.4. Pharmaceutical Drugs And Biologics Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Country;
7. Global Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors;
7.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, Global;
8. Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors Across Countries;
8.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, By Country;
9. Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.6. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.7. Global Average Spending On R&D/Product Development, 2016, By Country; 9.8. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.9. Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.10. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.11. Global Number Of Pharmacies, 2016, By Country; 9.12. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country; 9.13. Global New Drug Approvals, 2016, By Country; 9.14. Global Pharmaceutical Drugs And Biologics Market Revenue Versus New Drug Approvals, 2016, By Country; 9.15. Global Number Of General Practitioners 2016, By Country; 9.16. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Pharmaceutical Drugs And Biologics Market;
10.1.1. Asia-Pacific Pharmaceutical Drugs And Biologics Market Overview; 10.1.2. Asia-Pacific Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.2. Asia-Pacific Pharmaceutical Drugs And Biologics Market: Country Analysis; 10.3. China Pharmaceutical Drugs And Biologics Market; 10.3.1. China Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.3.2. China Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.3.3. China Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.3.4. China Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.3.5. China Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 10.4. India Pharmaceutical Drugs And Biologics Market; 10.4.1. India Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.4.2. India Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.4.3. India Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.4.4. India Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.4.5. India Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 10.5. Japan Pharmaceutical Drugs And Biologics Market; 10.5.1. Japan Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.5.2. Japan Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.5.3. Japan Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.5.4. Japan Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.5.5. Japan Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 10.5.7. Japan Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 10.5.7.1. Japan Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 10.5.7.2. Japan Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 10.6. Australia Pharmaceutical Drugs And Biologics Market; 10.6.1. Australia Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.6.2. Australia Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.6.3. Australia Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.6.4. Australia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020;
11. Western Europe Pharmaceutical Drugs And Biologics Market;
11.1.1. Western Europe Pharmaceutical Drugs And Biologics Market Overview; 11.1.2. Western Europe Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.1.3. Western Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.1.4. Western Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.2. Western Europe Pharmaceutical Drugs And Biologics Market: Country Analysis; 11.3. UK Pharmaceutical Drugs And Biologics Market; 11.3.1. UK Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 11.3.2. UK Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.3.3. UK Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.3.4. UK Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.3.5. UK Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.3.7. UK Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.3.7.1 UK Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.3.7.2 UK Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.4. Germany Pharmaceutical Drugs And Biologics Market; 11.4.1. Germany Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.4.2. Germany Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.4.3. Germany Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.4.4 Germany Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.4.6 Germany Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.4.7.1 Germany Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.4.7.2 Germany Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.5 France Pharmaceutical Drugs And Biologics Market; 11.5.1 France Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.5.2 France Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.5.3 France Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.5.4 France Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.5.6 France Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.5.6.1 France Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.5.6.2 France Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.6. Italy Pharmaceutical Drugs And Biologics Market; 11.6. Italy Pharmaceutical Drugs And Biologics Market; 11.6.1. Italy Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.6.2. Italy Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.6.3. Italy Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.6.4. Italy Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.6.6. Italy Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.6.6.1 Italy Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.6.6.2 Italy Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.7. Spain Pharmaceutical Drugs And Biologics Market; 11.7.1. Spain Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.7.2. Spain Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.7.3. Spain Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.7.4. Spain Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.7.6. Spain Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.7.6.1 Spain Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.7.6.2 Spain Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016;
12. Eastern Europe Pharmaceutical Drugs And Biologics Market;
12.1.1. Eastern Europe Pharmaceutical Drugs And Biologics Market Overview; 12.1.2. Eastern Europe Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 12.2. Eastern Europe Pharmaceutical Drugs And Biologics Market: Country Analysis; 12.3. Russia Pharmaceutical Drugs And Biologics Market; 12.3.1. Russia Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 12.3.2. Russia Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 12.3.3. Russia Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 12.3.4. Russia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020;
13. North America Pharmaceutical Drugs And Biologics Market;
13.1.1. North America Pharmaceutical Drugs And Biologics Market Overview; 13.1.2. North America Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 13.1.3. North America Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 13.1.4. North America Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 13.2. North America Pharmaceutical Drugs And Biologics Market: Country Analysis; 13.3. USA Pharmaceutical Drugs And Biologics Market; 13.3.1. USA Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 13.3.2. USA Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 13.3.3 USA Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 13.3.4. USA Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 13.3.6. USA Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 13.3.6.1 USA Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 13.3.6.2 USA Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016;
14. South America Pharmaceutical Drugs And Biologics Market;
14.1.1. South America Pharmaceutical Drugs And Biologics Market Overview; 14.1.2. South America Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 14.1.3. South America Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 14.1.4. South America Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 14.2. South America Pharmaceutical Drugs And Biologics Market: Country Analysis; 14.3. Brazil Pharmaceutical Drugs And Biologics Market; 14.3.1. Brazil Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 14.3.2. Brazil Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 14.3.3. Brazil Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 14.3.4. Brazil Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020;
15. Middle East Pharmaceutical Drugs And Biologics Market;
15.1.1. Middle East Pharmaceutical Drugs And Biologics Market Overview; 15.1.2. Middle East Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 15.1.3. Middle East Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 15.1.4. Middle East Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs;
16. Africa Pharmaceutical Drugs And Biologics Market;
16.1.1. Africa Pharmaceutical Drugs And Biologics Market Overview; 16.1.2. Africa Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 16.1.3. Africa Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 16.1.4. Africa Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Pharmaceutical Drugs;
17. Pharmaceutical Drugs And Biologics Market Competitive Landscape;
17.1. Company Profiles; 17.2. Pfizer; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Roche; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Glaxosmithkline; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Merck & Co.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Pharmaceutical Drugs And Biologics Market;
19. Market Background: Healthcare Market;
19.1.1. Healthcare Market Characteristics; 19.1.2. Healthcare Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Healthcare Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Healthcare Trends And Strategies; 19.2. Healthcare Market Regional And Country Analysis; 19.2.1. Global Healthcare Market, 2016, By Region; 19.2.2. Global Healthcare Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Healthcare Market, 2016, By Country; 19.2.4. Healthcare Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Healthcare Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Healthcare Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Healthcare Market Comparison With Macro Economic Factors; 19.3.1. Healthcare Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Healthcare Expenditure, Global; 19.4. Healthcare Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Healthcare Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Healthcare Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Healthcare Market;
20. Healthcare Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
2. Pharmaceutical Drugs And Biologics Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; Aging Populations; Emerging Markets Growth; Health Insurance Reforms; 2.1.2. Restraints On The Market; Patent Expiration Of Drugs; Pricing Pressures From Regulators; High Costs Of Drug Approval; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; Economic Growth; Technology; Changes In Lifestyles; New Methods For Drug Discovery; 2.2.2. Restraints On The Market; Cost; Interest Rate Increases; Reduction In Free Trade;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Pharmaceutical Drugs And Biologics Market Customer Information;
5. Pharmaceutical Drugs And Biologics Market Segmentation;
5.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 5.2. Global Pharmaceutical Drugs And Biologics Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Pharmaceutical Drugs And Biologics Market Trends And Strategies; Turning Away From Animal Testing; Increase In Personalized Medicine; Collaboration Driving Innovation; Increase In Mergers And Acquisitions; Rise Of Biologics/Gene Therapy; Aggressive Pricing Changes In Some Drugs; 5.4 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016; 5.5 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2012 – 2020, Historic and Forecast; 5.6 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Region; 5.7 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Country; 5.8 Pharmaceutical Drugs; 5.8.1. Market Characteristics; 5.8.2. Global Pharmaceutical Drugs Market, 2016, By Segment; 5.8.3. Global Pharmaceutical Drugs Market, 2012 – 2020, Historic and Forecast, By Segment; 5.8.4. Market Trends And Strategies; 5.9 Biologics; 5.9.1. Market Characteristics; 5.9.2. Global Biologics Market, 2016, By Segment; 5.9.3. Global Biologics Market, 2012 – 2020, Historic and Forecast, By Segment; 5.9.4. Market Trends And Strategies;
6. Pharmaceutical Drugs And Biologics Market Regional And Country Analysis;
6.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Region; 6.2. Global Pharmaceutical Drugs And Biologics Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Pharmaceutical Drugs And Biologics Market, 2016, By Country; 6.4. Pharmaceutical Drugs And Biologics Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Country;
7. Global Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors;
7.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, Global;
8. Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors Across Countries;
8.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, By Country;
9. Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.6. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.7. Global Average Spending On R&D/Product Development, 2016, By Country; 9.8. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.9. Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.10. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.11. Global Number Of Pharmacies, 2016, By Country; 9.12. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country; 9.13. Global New Drug Approvals, 2016, By Country; 9.14. Global Pharmaceutical Drugs And Biologics Market Revenue Versus New Drug Approvals, 2016, By Country; 9.15. Global Number Of General Practitioners 2016, By Country; 9.16. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Pharmaceutical Drugs And Biologics Market;
10.1.1. Asia-Pacific Pharmaceutical Drugs And Biologics Market Overview; 10.1.2. Asia-Pacific Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.2. Asia-Pacific Pharmaceutical Drugs And Biologics Market: Country Analysis; 10.3. China Pharmaceutical Drugs And Biologics Market; 10.3.1. China Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.3.2. China Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.3.3. China Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.3.4. China Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.3.5. China Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 10.4. India Pharmaceutical Drugs And Biologics Market; 10.4.1. India Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.4.2. India Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.4.3. India Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.4.4. India Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.4.5. India Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 10.5. Japan Pharmaceutical Drugs And Biologics Market; 10.5.1. Japan Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.5.2. Japan Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.5.3. Japan Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.5.4. Japan Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.5.5. Japan Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 10.5.7. Japan Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 10.5.7.1. Japan Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 10.5.7.2. Japan Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 10.6. Australia Pharmaceutical Drugs And Biologics Market; 10.6.1. Australia Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 10.6.2. Australia Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 10.6.3. Australia Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.6.4. Australia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020;
11. Western Europe Pharmaceutical Drugs And Biologics Market;
11.1.1. Western Europe Pharmaceutical Drugs And Biologics Market Overview; 11.1.2. Western Europe Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.1.3. Western Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.1.4. Western Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.2. Western Europe Pharmaceutical Drugs And Biologics Market: Country Analysis; 11.3. UK Pharmaceutical Drugs And Biologics Market; 11.3.1. UK Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 11.3.2. UK Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.3.3. UK Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.3.4. UK Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.3.5. UK Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.3.7. UK Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.3.7.1 UK Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.3.7.2 UK Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.4. Germany Pharmaceutical Drugs And Biologics Market; 11.4.1. Germany Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.4.2. Germany Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.4.3. Germany Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.4.4 Germany Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.4.6 Germany Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.4.7.1 Germany Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.4.7.2 Germany Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.5 France Pharmaceutical Drugs And Biologics Market; 11.5.1 France Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.5.2 France Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.5.3 France Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.5.4 France Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.5.6 France Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.5.6.1 France Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.5.6.2 France Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.6. Italy Pharmaceutical Drugs And Biologics Market; 11.6. Italy Pharmaceutical Drugs And Biologics Market; 11.6.1. Italy Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.6.2. Italy Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.6.3. Italy Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.6.4. Italy Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.6.6. Italy Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.6.6.1 Italy Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.6.6.2 Italy Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.7. Spain Pharmaceutical Drugs And Biologics Market; 11.7.1. Spain Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 11.7.2. Spain Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 11.7.3. Spain Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.7.4. Spain Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 11.7.6. Spain Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.7.6.1 Spain Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.7.6.2 Spain Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016;
12. Eastern Europe Pharmaceutical Drugs And Biologics Market;
12.1.1. Eastern Europe Pharmaceutical Drugs And Biologics Market Overview; 12.1.2. Eastern Europe Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 12.2. Eastern Europe Pharmaceutical Drugs And Biologics Market: Country Analysis; 12.3. Russia Pharmaceutical Drugs And Biologics Market; 12.3.1. Russia Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 12.3.2. Russia Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 12.3.3. Russia Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 12.3.4. Russia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020;
13. North America Pharmaceutical Drugs And Biologics Market;
13.1.1. North America Pharmaceutical Drugs And Biologics Market Overview; 13.1.2. North America Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 13.1.3. North America Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 13.1.4. North America Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 13.2. North America Pharmaceutical Drugs And Biologics Market: Country Analysis; 13.3. USA Pharmaceutical Drugs And Biologics Market; 13.3.1. USA Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 13.3.2. USA Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 13.3.3 USA Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 13.3.4. USA Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020; 13.3.6. USA Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 13.3.6.1 USA Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 13.3.6.2 USA Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016;
14. South America Pharmaceutical Drugs And Biologics Market;
14.1.1. South America Pharmaceutical Drugs And Biologics Market Overview; 14.1.2. South America Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 14.1.3. South America Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 14.1.4. South America Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 14.2. South America Pharmaceutical Drugs And Biologics Market: Country Analysis; 14.3. Brazil Pharmaceutical Drugs And Biologics Market; 14.3.1. Brazil Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 14.3.2. Brazil Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 14.3.3. Brazil Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 14.3.4. Brazil Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020;
15. Middle East Pharmaceutical Drugs And Biologics Market;
15.1.1. Middle East Pharmaceutical Drugs And Biologics Market Overview; 15.1.2. Middle East Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 15.1.3. Middle East Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 15.1.4. Middle East Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs;
16. Africa Pharmaceutical Drugs And Biologics Market;
16.1.1. Africa Pharmaceutical Drugs And Biologics Market Overview; 16.1.2. Africa Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016; 16.1.3. Africa Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020; 16.1.4. Africa Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Pharmaceutical Drugs;
17. Pharmaceutical Drugs And Biologics Market Competitive Landscape;
17.1. Company Profiles; 17.2. Pfizer; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Roche; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Glaxosmithkline; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Merck & Co.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Pharmaceutical Drugs And Biologics Market;
19. Market Background: Healthcare Market;
19.1.1. Healthcare Market Characteristics; 19.1.2. Healthcare Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Healthcare Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Healthcare Trends And Strategies; 19.2. Healthcare Market Regional And Country Analysis; 19.2.1. Global Healthcare Market, 2016, By Region; 19.2.2. Global Healthcare Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Healthcare Market, 2016, By Country; 19.2.4. Healthcare Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Healthcare Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Healthcare Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Healthcare Market Comparison With Macro Economic Factors; 19.3.1. Healthcare Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Healthcare Expenditure, Global; 19.4. Healthcare Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Healthcare Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Healthcare Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Healthcare Market;
20. Healthcare Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
